BSB PHARMA

Active

Private limited companyfounded 2022active for 4 yearsGroot-Bijgaardenstraat 405, 1082 Sint-Agatha-Berchem, BelgiumKBO/BCE: BE 0792.204.443

Summary

The computed 12-month bankruptcy probability of BSB PHARMA is 1.9% (moderate). The 2025 annual accounts show equity of €79,924 and a net result of €9,660. Equity is growing by about 29% per year across the filed financial years. Its solvency ranks better than 78% of 22,632 sector peers (NACE 47, financial year 2025). The company has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals.

Risk analysisFollow Report Compare

BSB PHARMAActiveChecked score 55/100

Risk analysis Report Compare

History

BSB PHARMA was incorporated on 7 October 2022 as a private limited company.¹ The registered office moved to Ganshoren in 2026 and to Berchem-Sainte-Agathe in 2026.²³ Since 2022, BEN SALEM Bassem has served as director of the company.⁴ Total assets rose from €64,430 in 2023 to €118,927 in 2025.⁵

Acts, filings and financial milestones

All 7Financial 1Gazette 3Filings 3

Next filing, financial year 2026, expected by 30-04-2027

2026

23-09

Gazette deed Registered office

Registered-office move2 facts ▸

General meeting, 01-09-2026
Registered-office move, Rue de Grand-Bigard 405, 1082 Berchem-Sainte-Agathe

27-05

Gazette deed Registered office

Registered-office move2 facts ▸

General meeting, 01-09-2025
Registered-office move, rue Georges Simpson 47 1083 Ganshoren

06-04

NBB filing Annual accounts filed

financial year 2025 · micro format

2025

30-09

Financial Weakest financial yearnet €9,660 ▼69.4%

Net result drops to €9,660, the lowest in the series.

29-04

NBB filing Annual accounts filed

financial year 2024 · micro format

2024

30-04

NBB filing Annual accounts filed

financial year 2023 · micro format

2022

11-10

Gazette deed Incorporation

Appointment: BEN SALEM Bassem (director) · Founder · Founding capital15 facts ▸

Founder, BEN SALEM Bassem (comparant)
Other provision, 06-10-2022
Other provision, “éclairage sur responsabilité du fondateur, faillite prononcée dans les trois ans de sa constitution” (deed in French)
Founding capital, €1,300
Bank account, 1300, “dépôt des apports en espèces de la société en formation” (deed in French)
Shareholding, 100
Capital
Registered office clause, “1190Forest,rueduCroissant86” (deed in French)
Other provision, “pharma.bsb@gmail.com, siteinternetetadresseélectronique” (deed in French)
Other provision, “informéobligationrenseignerbénéficiaireseffectifsregistreUBO, avertissements” (deed in French)
Pre-incorporation commitments, “takeover, tousengagementsobligationsrésultantettoutesactivitésentreprisesaunometpourcomptesociétéenformation” (deed in French)
General meeting, “assembléegénéraleextraordinaire, unanimitédesvoix” (deed in French)
+3 further facts in this act

Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.

3 of 3 deeds read